行业盛典 再启新程|第七届中国医药创新与投资大会初版日程发布

CHENG Xiaoliang

President, Jiangsu QLife Lab Technology Group Co., Ltd.

Dr. Cheng has dedicated to developing mass spectrometry technology and its clinical application for nearly two decades. He is an internationally renowned scientist in the field of metabolomics and clinical mass spectrometry technology and one the co-inventors of Qchip – the world-leading high-throughput mass spectrometry chip technology. He used to work at the Mass Spectrometry Technology Innovation Center of the Lawrence Berkeley National Laboratory, one of the top three mass spectrometry technology centers around the world. Dr. Cheng and his team have developed hundreds of technologies and patents for the screenings of early-diagnosis of diseases, drug development, and enzyme activity engineering. He was the only Chinese winner of the R&D 100 Awards (known as the “Oscar of Science and Technology”) in 2013. Dr. Cheng and his team have published over 100 peer-reviewed articles in such top academic journals as Lancet, Nature, Cell, and PNAS, obtained over 150 patents. Dr. Cheng also serves as the Vice Chairman of the Chinese Clinical Mass Spectrometry Research and Industry Union.